499 assets in Hepatocellular Carcinoma

Therapeutic assets addressing Hepatocellular Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
CSR02-Fab-TF Hepatocellular Carcinoma	Koo Foundation Sun Yat-Sen Cancer Center	Early P1	C (36)
nk521 cell Hepatocellular Carcinoma	Base Therapeutics (Shanghai) Co., Ltd.	Early P1	C (36)
sn301a Hepatocellular Carcinoma	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	Early P1	C (36)
Semaglutide Hepatocellular Carcinoma	University of Arizona	Early P1	C (34)
Tenofovir Amibufenamide Hepatocellular Carcinoma	Ningbo No.2 Hospital	Early P1	C (34)
Incb 086550 Hepatocellular Carcinoma	Incyte Corporation	P2	C (32)
Vobramitamab Duocarmazine Hepatocellular Carcinoma	MacroGenics	P1	C (32)
cg-102-12c Hepatocellular Carcinoma	Zhejiang University	N/A	D (30)
fd-001 Hepatocellular Carcinoma	Shanghai Zhongshan Hospital	N/A	D (30)
Fentanyl Hepatocellular Carcinoma	Iuliu Hatieganu University of Medicine and Pharmacy	N/A	D (30)
HT-102 Hepatocellular Carcinoma	Shanghai Zhongshan Hospital	N/A	D (30)
Human Interleukin 2 (Il2, T-Cell Growth Factor, Tcgf) (2-133) Variant (A1 Deleted, Pro65>Lys, Cys125>Ser), Non-Glycosylated, Produced In Escherichia Coli, Conjugated At N6 Of K65 With A Peg Derivative (30Kda) Hepatocellular Carcinoma	Sanofi	P2	D (30)
Immunoglobulin G4 [236-Proline], Anti-(Human Interleukin 1?) (Human Monoclonal Gensci048 ?4-Chain), Disulfide With Human Monoclonal Gensci048 ?-Chain, Dimer Hepatocellular Carcinoma	Tongji Hospital	N/A	D (30)
Incb099280 Hepatocellular Carcinoma	Abramson Cancer Center at Penn Medicine	P1	D (30)
Lidocaine Hepatocellular Carcinoma	Iuliu Hatieganu University of Medicine and Pharmacy	N/A	D (30)
Nepenthe Hepatocellular Carcinoma	Iuliu Hatieganu University of Medicine and Pharmacy	N/A	D (30)
Personalized Neoantigen Mrna Tumor Vaccine Hepatocellular Carcinoma	Shanghai Zhongshan Hospital	N/A	D (30)
Soluble Fluorescein Hepatocellular Carcinoma	Mayo Clinic	N/A	D (30)
Anti-Gpc3-Irdye800Cw Hepatocellular Carcinoma	Chinese Academy of Sciences	N/A	D (28)
Blood, Whole Hepatocellular Carcinoma	University Hospital, Angers	N/A	D (28)
Gadobutrol Hepatocellular Carcinoma	M.D. Anderson Cancer Center	N/A	D (28)
Hepatect Cp 50 I.E./Ml Infusion Hepatocellular Carcinoma	Medical University of Graz	N/A	D (28)
Nanrilkefusp Alfa Hepatocellular Carcinoma	SOTIO Biotech AG	P2	D (28)
Perflubutane Hepatocellular Carcinoma	Institute of Liver and Biliary Sciences, India	N/A	D (28)
Vic-1911 Hepatocellular Carcinoma	RenJi Hospital	N/A	D (28)
Brii-5395 Hepatocellular Carcinoma	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1	NR ()
bst02 Hepatocellular Carcinoma	BioSyngen Pte Ltd	P1	NR ()
Camerlizumab Hepatocellular Carcinoma	Shanghai Zhongshan Hospital	P2/3	NR ()
Certirobell® Hepatocellular Carcinoma	Yonsei University	P2	NR ()
Compound Cantharides Hepatocellular Carcinoma	Shanghai Zhongshan Hospital	P2/3	NR ()
ct-01 Hepatocellular Carcinoma	Captor Therapeutics S.A.	P1	NR ()
Donafina Hepatocellular Carcinoma	Jinling Hospital, China	P2	NR ()
Gkl-006 Hepatocellular Carcinoma	Beijing Gene Key Life Technology Co., Ltd	P2	NR ()
ha131 Hepatocellular Carcinoma	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	P1/2	NR ()
HH-009 Hepatocellular Carcinoma	Huahui Health	P1/2	NR ()
Ivarmacitinib Hepatocellular Carcinoma	First Affiliated Hospital of Chongqing Medical University	P2	NR ()
jdb153 Hepatocellular Carcinoma	West China Hospital	P1/2	NR ()
Metabolically Armed Gpc3 Car-T Cells Hepatocellular Carcinoma	Zhejiang University	Early P1	NR ()
pd-1/il-2 bispecific antibody fusion protein Hepatocellular Carcinoma	Shanghai Zhongshan Hospital	P2	NR ()
Retlirafusp Alfa Hepatocellular Carcinoma	Nanjing Tianyinshan Hospital	N/A	NR ()
Ropivacaine Hepatocellular Carcinoma	Sixth Affiliated Hospital, Sun Yat-sen University	N/A	NR ()
sz1003 Hepatocellular Carcinoma	Guangdong ProCapZoom Biosciences Co., Ltd.	Early P1	NR ()
Tilelizumab Hepatocellular Carcinoma	First Affiliated Hospital of Zhejiang University	P2	NR ()
Wgc-0201 Hepatocellular Carcinoma	West China Hospital	P1	NR ()

Showing 451 to 499 of 499 assets

PreviousPage 10 of 10Next